fenofibric acid has been researched along with Aging in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hitz, J; Siest, G; Steinmetz, J | 1 |
| Chicaud, P; Debry, G; Demange, J; Drouin, P | 1 |
| Andersson, Y; Fruchart, JC; Kosykh, V; Lefebvre, AM; Majd, Z; Martin, G; Najib, J; Sechkin, AV; Staels, B | 1 |
3 other study(ies) available for fenofibric acid and Aging
| Article | Year |
|---|---|
Plasma lecithin:cholesterol acyltransferase -- reference values and effects of xenobiotics.
Topics: Adolescent; Adult; Aging; Alcohol Drinking; Anticonvulsants; Child; Child, Preschool; Female; Fenofibrate; Humans; Hypolipidemic Agents; Male; Middle Aged; Phosphatidylcholine-Sterol O-Acyltransferase; Quality Control; Reference Values; Sex Factors | 1983 |
Application of the concanavalin A precipitation technique in an evaluation of fenofibrate action on cholesterolemia in IIa and IIb hyperlipemic subjects.
Topics: Adult; Aged; Aging; Anticholesteremic Agents; Chemical Precipitation; Cholesterol; Concanavalin A; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Propionates; Sex Factors | 1983 |
Developmental and pharmacological regulation of apolipoprotein C-II gene expression. Comparison with apo C-I and apo C-III gene regulation.
Topics: Aging; Animals; Apolipoprotein C-I; Apolipoprotein C-II; Apolipoprotein C-III; Apolipoproteins C; Fenofibrate; Gene Expression Regulation; Gene Expression Regulation, Developmental; Humans; Hypolipidemic Agents; Kinetics; Liver; Male; Rats; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Triglycerides | 1999 |